 | • レポートコード：MRC2102QY4465 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の二重バレル抗体薬市場について種類別（レモバブ、ビーリンサイト、その他）、用途別（肺がん、脳腫瘍、肝臓がん、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・二重バレル抗体薬市場の概要 ・世界の主要地域別二重バレル抗体薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の二重バレル抗体薬市場規模2015-2026：種類別（レモバブ、ビーリンサイト、その他） ・世界の二重バレル抗体薬市場規模2015-2026：用途別（肺がん、脳腫瘍、肝臓がん、その他） ・二重バレル抗体薬の米国市場規模2015-2020 ・二重バレル抗体薬のヨーロッパ市場規模2015-2020 ・二重バレル抗体薬の中国市場規模2015-2020 ・二重バレル抗体薬の日本市場規模2015-2020 ・二重バレル抗体薬の東南アジア市場規模2015-2020 ・二重バレル抗体薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・二重バレル抗体薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・二重バレル抗体薬の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Double Barreled Antibodies Drug Market
The global Double Barreled Antibodies Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Double Barreled Antibodies Drug Scope and Market Size
The global Double Barreled Antibodies Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Double Barreled Antibodies Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Double Barreled Antibodies Drug market is segmented into
Removab
BLINCYTO
Others
Segment by Application, the Double Barreled Antibodies Drug market is segmented into
Lung Cancer
Brain Cancer
Liver Cancer
Others
The Double Barreled Antibodies Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Double Barreled Antibodies Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Double Barreled Antibodies Drug Market Share Analysis
Double Barreled Antibodies Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Double Barreled Antibodies Drug business, the date to enter into the Double Barreled Antibodies Drug market, Double Barreled Antibodies Drug product introduction, recent developments, etc.
The major vendors covered:
Amgen Inc.
F. Hoffman La Roche Ltd.
AbbVie Inc.
OncoMed Pharmaceuticals, Inc.
Glenmark Pharmaceuticals Limited
Xencor, Inc.
MacroGenics, Inc.
Aptevo Therapeutics Inc.
Ligand Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Fresenius SE & Co. KGaA
Merus N.V.
1 Double Barreled Antibodies Drug Market Overview
1.1 Double Barreled Antibodies Drug Product Scope
1.2 Double Barreled Antibodies Drug Segment by Type
1.2.1 Global Double Barreled Antibodies Drug Sales by Type (2020-2026)
1.2.2 Removab
1.2.3 BLINCYTO
1.2.4 Others
1.3 Double Barreled Antibodies Drug Segment by Application
1.3.1 Global Double Barreled Antibodies Drug Sales Comparison by Application (2020-2026)
1.3.2 Lung Cancer
1.3.3 Brain Cancer
1.3.4 Liver Cancer
1.3.5 Others
1.4 Double Barreled Antibodies Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Double Barreled Antibodies Drug Sales Growth Rate (2015-2026)
1.4.2 Global Double Barreled Antibodies Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Double Barreled Antibodies Drug Price Trends (2015-2026)
2 Double Barreled Antibodies Drug Estimate and Forecast by Region
2.1 Global Double Barreled Antibodies Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Double Barreled Antibodies Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Double Barreled Antibodies Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Double Barreled Antibodies Drug Revenue Market Share by Region (2015-2020)
2.3 Global Double Barreled Antibodies Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Double Barreled Antibodies Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Double Barreled Antibodies Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Double Barreled Antibodies Drug Estimates and Projections (2015-2026)
2.4.2 Europe Double Barreled Antibodies Drug Estimates and Projections (2015-2026)
2.4.3 China Double Barreled Antibodies Drug Estimates and Projections (2015-2026)
2.4.4 Japan Double Barreled Antibodies Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Double Barreled Antibodies Drug Estimates and Projections (2015-2026)
2.4.6 India Double Barreled Antibodies Drug Estimates and Projections (2015-2026)
3 Global Double Barreled Antibodies Drug Competition Landscape by Players
3.1 Global Top Double Barreled Antibodies Drug Players by Sales (2015-2020)
3.2 Global Top Double Barreled Antibodies Drug Players by Revenue (2015-2020)
3.3 Global Double Barreled Antibodies Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Double Barreled Antibodies Drug as of 2019)
3.4 Global Double Barreled Antibodies Drug Average Price by Company (2015-2020)
3.5 Manufacturers Double Barreled Antibodies Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Double Barreled Antibodies Drug Players (Opinion Leaders)
4 Global Double Barreled Antibodies Drug Market Size by Type
4.1 Global Double Barreled Antibodies Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Double Barreled Antibodies Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Double Barreled Antibodies Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Double Barreled Antibodies Drug Price by Type (2015-2020)
4.2 Global Double Barreled Antibodies Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Double Barreled Antibodies Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Double Barreled Antibodies Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Double Barreled Antibodies Drug Price Forecast by Type (2021-2026)
5 Global Double Barreled Antibodies Drug Market Size by Application
5.1 Global Double Barreled Antibodies Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Double Barreled Antibodies Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Double Barreled Antibodies Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Double Barreled Antibodies Drug Price by Application (2015-2020)
5.2 Global Double Barreled Antibodies Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Double Barreled Antibodies Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Double Barreled Antibodies Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Double Barreled Antibodies Drug Price Forecast by Application (2021-2026)
6 United States Double Barreled Antibodies Drug Market Facts & Figures
6.1 United States Double Barreled Antibodies Drug Sales Market Share by Company (2015-2020)
6.2 United States Double Barreled Antibodies Drug Sales Market Share by Type (2015-2020)
6.3 United States Double Barreled Antibodies Drug Sales Market Share by Application (2015-2020)
7 Europe Double Barreled Antibodies Drug Market Facts & Figures
7.1 Europe Double Barreled Antibodies Drug Sales Market Share by Company (2015-2020)
7.2 Europe Double Barreled Antibodies Drug Sales Market Share by Type (2015-2020)
7.3 Europe Double Barreled Antibodies Drug Sales Market Share by Application (2015-2020)
8 China Double Barreled Antibodies Drug Market Facts & Figures
8.1 China Double Barreled Antibodies Drug Sales Market Share by Company (2015-2020)
8.2 China Double Barreled Antibodies Drug Sales Market Share by Type (2015-2020)
8.3 China Double Barreled Antibodies Drug Sales Market Share by Application (2015-2020)
9 Japan Double Barreled Antibodies Drug Market Facts & Figures
9.1 Japan Double Barreled Antibodies Drug Sales Market Share by Company (3015-3030)
9.2 Japan Double Barreled Antibodies Drug Sales Market Share by Type (2015-2020)
9.3 Japan Double Barreled Antibodies Drug Sales Market Share by Application (2015-2020)
10 Southeast Asia Double Barreled Antibodies Drug Market Facts & Figures
10.1 Southeast Asia Double Barreled Antibodies Drug Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Double Barreled Antibodies Drug Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Double Barreled Antibodies Drug Sales Market Share by Application (2015-2020)
11 India Double Barreled Antibodies Drug Market Facts & Figures
11.1 India Double Barreled Antibodies Drug Sales Market Share by Company (2015-2020)
11.2 India Double Barreled Antibodies Drug Sales Market Share by Type (2015-2020)
11.3 India Double Barreled Antibodies Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Double Barreled Antibodies Drug Business
12.1 Amgen Inc.
12.1.1 Amgen Inc. Corporation Information
12.1.2 Amgen Inc. Business Overview
12.1.3 Amgen Inc. Double Barreled Antibodies Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Amgen Inc. Double Barreled Antibodies Drug Products Offered
12.1.5 Amgen Inc. Recent Development
12.2 F. Hoffman La Roche Ltd.
12.2.1 F. Hoffman La Roche Ltd. Corporation Information
12.2.2 F. Hoffman La Roche Ltd. Business Overview
12.2.3 F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Products Offered
12.2.5 F. Hoffman La Roche Ltd. Recent Development
12.3 AbbVie Inc.
12.3.1 AbbVie Inc. Corporation Information
12.3.2 AbbVie Inc. Business Overview
12.3.3 AbbVie Inc. Double Barreled Antibodies Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 AbbVie Inc. Double Barreled Antibodies Drug Products Offered
12.3.5 AbbVie Inc. Recent Development
12.4 OncoMed Pharmaceuticals, Inc.
12.4.1 OncoMed Pharmaceuticals, Inc. Corporation Information
12.4.2 OncoMed Pharmaceuticals, Inc. Business Overview
12.4.3 OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Products Offered
12.4.5 OncoMed Pharmaceuticals, Inc. Recent Development
12.5 Glenmark Pharmaceuticals Limited
12.5.1 Glenmark Pharmaceuticals Limited Corporation Information
12.5.2 Glenmark Pharmaceuticals Limited Business Overview
12.5.3 Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Products Offered
12.5.5 Glenmark Pharmaceuticals Limited Recent Development
12.6 Xencor, Inc.
12.6.1 Xencor, Inc. Corporation Information
12.6.2 Xencor, Inc. Business Overview
12.6.3 Xencor, Inc. Double Barreled Antibodies Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Xencor, Inc. Double Barreled Antibodies Drug Products Offered
12.6.5 Xencor, Inc. Recent Development
12.7 MacroGenics, Inc.
12.7.1 MacroGenics, Inc. Corporation Information
12.7.2 MacroGenics, Inc. Business Overview
12.7.3 MacroGenics, Inc. Double Barreled Antibodies Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 MacroGenics, Inc. Double Barreled Antibodies Drug Products Offered
12.7.5 MacroGenics, Inc. Recent Development
12.8 Aptevo Therapeutics Inc.
12.8.1 Aptevo Therapeutics Inc. Corporation Information
12.8.2 Aptevo Therapeutics Inc. Business Overview
12.8.3 Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Products Offered
12.8.5 Aptevo Therapeutics Inc. Recent Development
12.9 Ligand Pharmaceuticals, Inc.
12.9.1 Ligand Pharmaceuticals, Inc. Corporation Information
12.9.2 Ligand Pharmaceuticals, Inc. Business Overview
12.9.3 Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Products Offered
12.9.5 Ligand Pharmaceuticals, Inc. Recent Development
12.10 Regeneron Pharmaceuticals, Inc.
12.10.1 Regeneron Pharmaceuticals, Inc. Corporation Information
12.10.2 Regeneron Pharmaceuticals, Inc. Business Overview
12.10.3 Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Products Offered
12.10.5 Regeneron Pharmaceuticals, Inc. Recent Development
12.11 Fresenius SE & Co. KGaA
12.11.1 Fresenius SE & Co. KGaA Corporation Information
12.11.2 Fresenius SE & Co. KGaA Business Overview
12.11.3 Fresenius SE & Co. KGaA Double Barreled Antibodies Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Fresenius SE & Co. KGaA Double Barreled Antibodies Drug Products Offered
12.11.5 Fresenius SE & Co. KGaA Recent Development
12.12 Merus N.V.
12.12.1 Merus N.V. Corporation Information
12.12.2 Merus N.V. Business Overview
12.12.3 Merus N.V. Double Barreled Antibodies Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Merus N.V. Double Barreled Antibodies Drug Products Offered
12.12.5 Merus N.V. Recent Development
13 Double Barreled Antibodies Drug Manufacturing Cost Analysis
13.1 Double Barreled Antibodies Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Double Barreled Antibodies Drug
13.4 Double Barreled Antibodies Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Double Barreled Antibodies Drug Distributors List
14.3 Double Barreled Antibodies Drug Customers
15 Market Dynamics
15.1 Double Barreled Antibodies Drug Market Trends
15.2 Double Barreled Antibodies Drug Opportunities and Drivers
15.3 Double Barreled Antibodies Drug Market Challenges
15.4 Double Barreled Antibodies Drug Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Double Barreled Antibodies Drug Sales (K Pcs) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Double Barreled Antibodies Drug Sales (K Pcs) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Double Barreled Antibodies Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Double Barreled Antibodies Drug Sales (K Pcs) by Region (2015-2020)
Table 5. Global Double Barreled Antibodies Drug Sales Market Share by Region (2015-2020)
Table 6. Global Double Barreled Antibodies Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Double Barreled Antibodies Drug Revenue Share by Region (2015-2020)
Table 8. Global Double Barreled Antibodies Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Double Barreled Antibodies Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Double Barreled Antibodies Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Double Barreled Antibodies Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Double Barreled Antibodies Drug (K Pcs) of Key Companies (2015-2020)
Table 13. Global Double Barreled Antibodies Drug Sales Share by Company (2015-2020)
Table 14. Global Double Barreled Antibodies Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Double Barreled Antibodies Drug Revenue Share by Company (2015-2020)
Table 16. Global Double Barreled Antibodies Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Double Barreled Antibodies Drug as of 2019)
Table 17. Global Double Barreled Antibodies Drug Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Double Barreled Antibodies Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Double Barreled Antibodies Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Double Barreled Antibodies Drug Players
Table 22. Global Double Barreled Antibodies Drug Sales (K Pcs) by Type (2015-2020)
Table 23. Global Double Barreled Antibodies Drug Sales Share by Type (2015-2020)
Table 24. Global Double Barreled Antibodies Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Double Barreled Antibodies Drug Price (K Pcs) by Type (2015-2020)
Table 26. Global Double Barreled Antibodies Drug Sales Share by Type (2021-2026)
Table 27. Global Double Barreled Antibodies Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Double Barreled Antibodies Drug Revenue Share by Type (2021-2026)
Table 29. Global Double Barreled Antibodies Drug Price (K Pcs) by Type (2021-2026)
Table 30. Global Double Barreled Antibodies Drug Sales (K Pcs) by Application (2015-2020)
Table 31. Global Double Barreled Antibodies Drug Sales Share by Application (2015-2020)
Table 32. Global Double Barreled Antibodies Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Double Barreled Antibodies Drug Price (K Pcs) by Application (2015-2020)
Table 34. Global Double Barreled Antibodies Drug Sales (K Pcs) by Application (2021-2026)
Table 35. Global Double Barreled Antibodies Drug Sales Share by Application (2021-2026)
Table 36. Global Double Barreled Antibodies Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Double Barreled Antibodies Drug Revenue Share by Application (2021-2026)
Table 38. Global Double Barreled Antibodies Drug Price (K Pcs) by Application (2021-2026)
Table 39. United States Double Barreled Antibodies Drug Sales (K Pcs) by Company (2015-2020)
Table 40. United States Double Barreled Antibodies Drug Sales Market Share by Company (2015-2020)
Table 41. United States Double Barreled Antibodies Drug Sales (K Pcs) by Type (2015-2020)
Table 42. United States Double Barreled Antibodies Drug Sales Market Share by Type (2015-2020)
Table 43. United States Double Barreled Antibodies Drug Sales (K Pcs) by Application (2015-2020)
Table 44. United States Double Barreled Antibodies Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Double Barreled Antibodies Drug Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Double Barreled Antibodies Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Double Barreled Antibodies Drug Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Double Barreled Antibodies Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Double Barreled Antibodies Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Double Barreled Antibodies Drug Sales Market Share by Type (2015-2020)
Table 51. China Double Barreled Antibodies Drug Sales (K Pcs) by Company (2015-2020)
Table 52. China Double Barreled Antibodies Drug Sales Market Share by Company (2015-2020)
Table 53. China Double Barreled Antibodies Drug Sales (K Pcs) by Type (2015-2020)
Table 54. China Double Barreled Antibodies Drug Sales Market Share by Type (2015-2020)
Table 55. China Double Barreled Antibodies Drug Sales (K Pcs) by Application (2015-2020)
Table 56. China Double Barreled Antibodies Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Double Barreled Antibodies Drug Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Double Barreled Antibodies Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Double Barreled Antibodies Drug Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Double Barreled Antibodies Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Double Barreled Antibodies Drug Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Double Barreled Antibodies Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Double Barreled Antibodies Drug Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Double Barreled Antibodies Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Double Barreled Antibodies Drug Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Double Barreled Antibodies Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Double Barreled Antibodies Drug Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Double Barreled Antibodies Drug Sales Market Share by Application (2015-2020)
Table 69. India Double Barreled Antibodies Drug Sales (K Pcs) by Company (2015-2020)
Table 70. India Double Barreled Antibodies Drug Sales Market Share by Company (2015-2020)
Table 71. India Double Barreled Antibodies Drug Sales (K Pcs) by Type (2015-2020)
Table 72. India Double Barreled Antibodies Drug Sales Market Share by Type (2015-2020)
Table 73. India Double Barreled Antibodies Drug Sales (K Pcs) by Application (2015-2020)
Table 74. India Double Barreled Antibodies Drug Sales Market Share by Application (2015-2020)
Table 75. Amgen Inc. Corporation Information
Table 76. Amgen Inc. Description and Business Overview
Table 77. Amgen Inc. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. Amgen Inc. Double Barreled Antibodies Drug Product
Table 79. Amgen Inc. Recent Development
Table 80. F. Hoffman La Roche Ltd. Corporation Information
Table 81. F. Hoffman La Roche Ltd. Description and Business Overview
Table 82. F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. F. Hoffman La Roche Ltd. Double Barreled Antibodies Drug Product
Table 84. F. Hoffman La Roche Ltd. Recent Development
Table 85. AbbVie Inc. Corporation Information
Table 86. AbbVie Inc. Description and Business Overview
Table 87. AbbVie Inc. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. AbbVie Inc. Double Barreled Antibodies Drug Product
Table 89. AbbVie Inc. Recent Development
Table 90. OncoMed Pharmaceuticals, Inc. Corporation Information
Table 91. OncoMed Pharmaceuticals, Inc. Description and Business Overview
Table 92. OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. OncoMed Pharmaceuticals, Inc. Double Barreled Antibodies Drug Product
Table 94. OncoMed Pharmaceuticals, Inc. Recent Development
Table 95. Glenmark Pharmaceuticals Limited Corporation Information
Table 96. Glenmark Pharmaceuticals Limited Description and Business Overview
Table 97. Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Glenmark Pharmaceuticals Limited Double Barreled Antibodies Drug Product
Table 99. Glenmark Pharmaceuticals Limited Recent Development
Table 100. Xencor, Inc. Corporation Information
Table 101. Xencor, Inc. Description and Business Overview
Table 102. Xencor, Inc. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 103. Xencor, Inc. Double Barreled Antibodies Drug Product
Table 104. Xencor, Inc. Recent Development
Table 105. MacroGenics, Inc. Corporation Information
Table 106. MacroGenics, Inc. Description and Business Overview
Table 107. MacroGenics, Inc. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 108. MacroGenics, Inc. Double Barreled Antibodies Drug Product
Table 109. MacroGenics, Inc. Recent Development
Table 110. Aptevo Therapeutics Inc. Corporation Information
Table 111. Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 112. Aptevo Therapeutics Inc. Description and Business Overview
Table 113. Aptevo Therapeutics Inc. Double Barreled Antibodies Drug Product
Table 114. Aptevo Therapeutics Inc. Recent Development
Table 115. Ligand Pharmaceuticals, Inc. Corporation Information
Table 116. Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 117. Ligand Pharmaceuticals, Inc. Description and Business Overview
Table 118. Ligand Pharmaceuticals, Inc. Double Barreled Antibodies Drug Product
Table 119. Ligand Pharmaceuticals, Inc. Recent Development
Table 120. Regeneron Pharmaceuticals, Inc. Corporation Information
Table 121. Regeneron Pharmaceuticals, Inc. Description and Business Overview
Table 122. Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 123. Regeneron Pharmaceuticals, Inc. Double Barreled Antibodies Drug Product
Table 124. Regeneron Pharmaceuticals, Inc. Recent Development
Table 125. Fresenius SE & Co. KGaA Corporation Information
Table 126. Fresenius SE & Co. KGaA Description and Business Overview
Table 127. Fresenius SE & Co. KGaA Double Barreled Antibodies Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 128. Fresenius SE & Co. KGaA Double Barreled Antibodies Drug Product
Table 129. Fresenius SE & Co. KGaA Recent Development
Table 130. Merus N.V. Corporation Information
Table 131. Merus N.V. Description and Business Overview
Table 132. Merus N.V. Double Barreled Antibodies Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 133. Merus N.V. Double Barreled Antibodies Drug Product
Table 134. Merus N.V. Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Double Barreled Antibodies Drug Distributors List
Table 138. Double Barreled Antibodies Drug Customers List
Table 139. Double Barreled Antibodies Drug Market Key Trends
Table 140. Double Barreled Antibodies Drug Key Opportunities and Drivers
Table 141. Double Barreled Antibodies Drug Market Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Double Barreled Antibodies Drug Product Picture
Figure 2. Global Double Barreled Antibodies Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Double Barreled Antibodies Drug Market Share by Application in 2020 & 2026
Figure 6. Lung Cancer Examples
Figure 7. Brain Cancer Examples
Figure 8. Liver Cancer Examples
Figure 9. Others Examples
Figure 10. Global Double Barreled Antibodies Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 11. Global Double Barreled Antibodies Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Double Barreled Antibodies Drug Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 13. Global Double Barreled Antibodies Drug Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Double Barreled Antibodies Drug Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Double Barreled Antibodies Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Double Barreled Antibodies Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 17. Europe Double Barreled Antibodies Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Double Barreled Antibodies Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Double Barreled Antibodies Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Double Barreled Antibodies Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Double Barreled Antibodies Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Double Barreled Antibodies Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Double Barreled Antibodies Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Double Barreled Antibodies Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Double Barreled Antibodies Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Double Barreled Antibodies Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Double Barreled Antibodies Drug Players Market Share by Revenue in Double Barreled Antibodies Drug 2015 & 2019
Figure 28. Double Barreled Antibodies Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Double Barreled Antibodies Drug Revenue Share by Type (2015-2020)
Figure 30. Global Double Barreled Antibodies Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Double Barreled Antibodies Drug Revenue Share by Application (2015-2020)
Figure 32. Global Double Barreled Antibodies Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Double Barreled Antibodies Drug Sales Market Share by Type in 2019
Figure 34. United States Double Barreled Antibodies Drug Sales Market Share by Type in 2019
Figure 35. Europe Double Barreled Antibodies Drug Sales Market Share by Company in 2019
Figure 36. Europe Double Barreled Antibodies Drug Sales Market Share by Type in 2019
Figure 37. Europe Double Barreled Antibodies Drug Sales Market Share by Application in 2019
Figure 38. China Double Barreled Antibodies Drug Sales Market Share by Company in 2019
Figure 39. China Double Barreled Antibodies Drug Sales Market Share by Type in 2019
Figure 40. China Double Barreled Antibodies Drug Sales Market Share by Application in 2019
Figure 41. Japan Double Barreled Antibodies Drug Sales Market Share by Company in 2019
Figure 42. Japan Double Barreled Antibodies Drug Sales Market Share by Type in 2019
Figure 43. Japan Double Barreled Antibodies Drug Sales Market Share by Application in 2019
Figure 44. Southeast Asia Double Barreled Antibodies Drug Sales Market Share by Company in 2019
Figure 45. Southeast Asia Double Barreled Antibodies Drug Sales Market Share by Type in 2019
Figure 46. Southeast Asia Double Barreled Antibodies Drug Sales Market Share by Application in 2019
Figure 47. India Double Barreled Antibodies Drug Sales Market Share by Company in 2019
Figure 48. India Double Barreled Antibodies Drug Sales Market Share by Type in 2019
Figure 49. India Double Barreled Antibodies Drug Sales Market Share by Application in 2019
Figure 50. Key Raw Materials Price Trend
Figure 51. Manufacturing Cost Structure of Double Barreled Antibodies Drug
Figure 52. Manufacturing Process Analysis of Double Barreled Antibodies Drug
Figure 53. Double Barreled Antibodies Drug Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Porter's Five Forces Analysis
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
低分子がん治療薬の世界市場レポート2020 Market Analysis and Insights: Global Small Molecule Cancer Drug Market The global Small Molecule Cancer Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Small Molecule Cancer Drug Scope and Market Size The global Sm…- バイオシミラーモノクローナル抗体の世界市場レポート2020 Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are calle…
- 抗体＆試薬研究の世界市場レポート2020 Market Analysis and Insights: Global Research Antibodies and Reagents Market The global Research Antibodies and Reagents market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Research Antibodies and Reagents Scope and Market …
- 二次抗体の世界市場レポート2020 Market Analysis and Insights: Global Secondary Antibodies Market The global Secondary Antibodies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Secondary Antibodies Scope and Market Size The global Secondary Antibodies…
- CD抗原がん治療の世界市場レポート2020 Market Analysis and Insights: Global CD Antigen Cancer Therapy Market The global CD Antigen Cancer Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global CD Antigen Cancer Therapy Scope and Market Size The global CD An…